You have read all your free articles, to continue reading subscribe to read the rest of this content.
Medivir today reports that that simeprevir has been approved for the treatment of genotype 1 chronic hepatitis C virus (HCV) infection. "The approval in Japan is a very important step in providing patients with new treatment options. It is the first approval based on the series of global filingAlready a…
Ultomiris (ravulizumab) has been approved in the European Union for expanded use to include children and adolescents with paroxysmal nocturnal haemoglobinuria (PNH), an ultra-rare and severe blood disorder characterized by the destruction of red blood cells that can cause thrombosis (blood clots) anAlready a subscriber Login You have read all…
Devyser Diagnostics has announced its intention to launch an initial public offering of its shares and to list its shares on Nasdaq First North Premier Growth Market. The offering is expected to consist of both new shares issued by Devyser and of existing shares in the company. Nasdaq has announcAlready…
The aim of the new award is to celebrate people from KTH who, with their innovations, have contributed to a better society. The monetary award is 500,000 Swedish crowns (EUR 49,500). A recipient of the KTH Innovation Award can be one or several individuals who are, or have been, affiliated…
